Breast milk kills HIV and blocks its oral transmission in humanized mouse
More than 15 percent of new HIV infections occur in children. Without treatment, only 65 percent of HIV-infected children will live until their first birthday, and fewer than half will make it to the age of ...
HIV & AIDS
Jun 14, 2012 |
5 / 5 (5) |
0
|
Will women use microbicides to protect themselves against HIV?
Are women willing to use a vaginal gel to protect themselves against HIV infection? Researchers at The Miriam Hospital say that is the million dollar question when it comes to developing products known as microbicides that ...
HIV & AIDS
Apr 19, 2012 |
5 / 5 (1) |
0
Rectal formulation of tenofovir gel safe and acceptable in early phase clinical study
A gel formulation of the antiretroviral drug tenofovir designed specifically for rectal use was found safe and acceptable, according to a Phase I clinical study led by the U.S. National Institutes of Health (NIH)-funded Microbicide ...
HIV & AIDS
Mar 06, 2012 |
not rated yet |
0
Business, social media to prevent babies with HIV
(AP) -- Business and social media leaders teamed up Friday to tackle the transmission of HIV from mothers to babies, saying the medicine and the money are largely in place, and with the right organizational skills they can ...
HIV & AIDS
Jan 27, 2012 |
not rated yet |
0
Revamping HIV-prevention programs in the Caribbean
While global attention to HIV/AIDS remains strong, a lack of focus on prevention strategies is stonewalling health experts in many developing nations, specifically in the Caribbean.
HIV & AIDS
Jan 19, 2012 |
not rated yet |
0
Viral load a major factor affecting risk of sexually transmitting HIV
The level of HIV-1 in the blood of an HIV-infected partner is the single most important factor influencing risk of sexual transmission to an uninfected partner, according to a multinational study of heterosexual couples in ...
HIV & AIDS
Jan 12, 2012 |
4.5 / 5 (2) |
0
|
HIV prevention research named scientific breakthrough of the year by Science
The HIV Prevention Trials Network 052 study, led by Myron S. Cohen, MD of the University of North Carolina at Chapel Hill, has been named the 2011 Breakthrough of the Year by the journal Science.
HIV & AIDS
Dec 22, 2011 |
5 / 5 (3) |
3
|
Abolish the criminalization of HIV
Routine criminal prosecutions for not disclosing HIV status should be abolished, write three HIV/AIDS experts in an article in CMAJ (Canadian Medical Association Journal).
HIV & AIDS
Dec 19, 2011 |
not rated yet |
7
HIV spreading in Europe, but AIDS cases declining: study
HIV infections continued to rise in Europe in 2010, but thanks to treatment the number of cases of full-blown AIDS has dramatically declined in recent years, according to a report published Wednesday.
HIV & AIDS
Nov 30, 2011 |
3 / 5 (2) |
0
HIV trial scrapped after gel found to be ineffective
In a major setback for AIDS prevention research, a clinical trial of a new vaginal gel supposed to reduce HIV infections has been suspended after studies showed it to be ineffective.
HIV & AIDS
Nov 27, 2011 |
not rated yet |
2
Could engineered fatty particles help prevent AIDS?
Could engineered fatty particles help prevent AIDS? Liposomes block HIV infection in early tests; could be a cost-effective preventive for developing countries
HIV & AIDS
Sep 19, 2011 |
5 / 5 (1) |
1
|
Breast milk antibody fights HIV but needs boost
Breast milk antibody both neutralizes human immunodeficiency virus (HIV) and kills HIV-infected cells, according to a paper in the September 2011 issue of the Journal of Virology.
HIV & AIDS
Sep 19, 2011 |
not rated yet |
0
First large study to find HIV epidemic among gays in the Middle East
HIV epidemics are emerging in several countries in the Middle East and North Africa among men who have sex with men, a term that encompasses gay, non-gay identified homosexual men, and transgendered and bisexual men.
HIV & AIDS
Aug 03, 2011 |
5 / 5 (1) |
9
Clinical tests for medicines made from genetically modified plants
UK regulators have approved Europe's first clinical trial of a monoclonal antibody produced from genetically modified plants. This landmark decision sets the stage for the testing, in humans, of an anti-HIV product made from ...
Other
Jul 21, 2011 |
not rated yet |
0
Preventing the spread of HIV/AIDS with humanized BLT mice
The more than 2.7 million new HIV infections recorded per year leave little doubt that the HIV/AIDS epidemic continues to spread globally. That's why there's the need for safe, inexpensive and effective drugs to successfully ...
HIV & AIDS
May 18, 2011 |
3 / 5 (1) |
0
|
